Acute Porphyria Drug Database

Monograph

A07EC03 - Olsalazine
Propably not porphyrinogenic
PNP

Rationale
Relatively low systemic exposure of substance with probably non-CYP metabolism. Acetyl salicylic acid is an inducer of CYP 2C19 Two references state non-porphyrinogenicity.
Chemical description
Antiinflammatory agent perorally used 1 g/d, in ulcerating colitis. Composed of two mesalazine ( 5-amino-salicylic acid) molecules joined by azo-bonding. Only insignificantly (1-2 %) absorbed, split by colon bacteria into two 5-ASA, which is acetylated in the gut and the liver. mesalazine: South African list: use. EPI-list: use

Similar drugs
Explore alternative drugs in similar therapeutic classes A07E / A07EC or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Dipentum · Dipentum 250 mg, harde capsules · Dipentum 500 mg, tabletten
United Kingdom
Dipentum · Dipentum 250mg capsules · Dipentum 500mg tablets · Olsalazine · Olsalazine 250mg capsules · Olsalazine 250mg/5ml oral solution · Olsalazine 250mg/5ml oral suspension · Olsalazine 500mg tablets
Denmark
Dipentum
Norway
Dipentum
Iceland
Dipentum
Finland
Dipentum
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙